News

AevisBio entered into a collaborative research with KRIBB

관리자 │ 2023-01-17

HIT

475

In July of 2019, AevisBio and Korea Research Institute of Bioscience & Biotechnology (KRIBB) announced a collaboration to discover, develop, and commercialize therapies for treating disease of aging, including Parkinson’s disease. 


Previous Post Bio Research Center founded at Bio Venture Center, KRIBB
Next Post Korean Government grant (TIPS) awarded